Publicaciones en colaboración con investigadoras/es de VU University Medical Center (46)

2017

  1. The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia

    Pharmacogenetics and Genomics, Vol. 27, Núm. 8, pp. 303-306

2016

  1. A cellular reporter to evaluate CRM1 nuclear export activity: functional analysis of the cancer-related mutant E571K

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 24, pp. 4685-4699

2014

  1. Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variant

    Human Molecular Genetics, Vol. 23, Núm. 9, pp. 2481-2489

2013

  1. USP1 deubiquitinase: Cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy

    Molecular Cancer, Vol. 12, Núm. 1

2011

  1. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease

    Nature Genetics, Vol. 43, Núm. 12, pp. 1193-1201

2009

  1. Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

    British Journal of Cancer, Vol. 100, Núm. 1, pp. 145-152

2008

  1. Apoptosis pathways and new anticancer agents

    Principles of Molecular Oncology: Third Edition (Humana Press), pp. 257-268

  2. Genotype analysis of the VNTR polymorphism in the SMYD3 histone methyltransferase gene: Lack of correlation with the level of histone H3 methylation in NSCLC tissues or with the risk of NSCLC

    International Journal of Cancer

  3. Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target

    PLoS ONE, Vol. 3, Núm. 3

  4. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells

    Molecular Pharmacology, Vol. 73, Núm. 4, pp. 1290-1300

  5. Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

    Annals of Oncology, Vol. 19, Núm. 9, pp. 1605-1612

2007

  1. Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCl-H460

    Molecular Cancer Therapeutics, Vol. 6, Núm. 3, pp. 1046-1053

  2. EGFR and K-ras mutation analysis in non-small cell lung cancer: Comparison of paraffin embedded versus frozen specimens

    Cellular Oncology, Vol. 29, Núm. 3, pp. 257-264

  3. Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization

    Histopathology, Vol. 51, Núm. 5, pp. 631-637

  4. Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain

    Molecular Cancer, Vol. 6

  5. Genetic heterogeneity in patients with multiple neoplastic lung lesions: A report of three cases

    Journal of Thoracic Oncology, Vol. 2, Núm. 1, pp. 12-21

  6. Homodimerization antagonizes nuclear export of Survivin

    Traffic, Vol. 8, Núm. 11, pp. 1495-1502

  7. Immunohistochemical detection of nuclear survivin in NSCLC: A comparison of commercial antibodies [6]

    Histopathology

  8. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax

    Cancer Letters, Vol. 250, Núm. 2, pp. 177-193

  9. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: A small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation

    Experimental Cell Research, Vol. 313, Núm. 6, pp. 1215-1224